Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial.

Trials · 2014 · PMC3926690 · PMID 24398143

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

One propensity score matched registry (LESSON-1) showed a trend towards a lower risk of death, myocardial infarction (MI) and target-vessel revascularization (TVR) as compared to SES over a 3-year follow-up [ 8 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.